Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ralph Salloum, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Stanford University and Lucile Packard Children'S Hospital
Palo Alto, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida
Gainesville, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- St. Jude Children Research Hospital
Memphis, Tennessee, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jul 2019
- Primary completion
- 11 Aug 2025
- Completion
- 11 Aug 2025
- Last update posted
- 30 Oct 2025
- Registered enrollment
- 21
- Registry id
- NCT03904862
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.